Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02412683|
Recruitment Status : Completed
First Posted : April 9, 2015
Last Update Posted : September 7, 2016
Subgroups of patients with radically operated colorectal cancer can have a better prognosis by over six months are treated with chemotherapy. This beneficial effect may be enhanced somewhat by providing a combination of chemotherapy and the addition of oxaliplatin. It is known that this treatment additions increase the risk of neurotoxic side effects such as sensitivity to cold, numbness and tingling in hands or feet, muscle cramps, pain, taste disorders and swallowing difficulties.
The aim is to investigate how colorectal cancer patients with oxaliplatin adjuvant chemotherapy experience neurotoxic effects and if the experience of the symptoms change over time during treatment and how symptoms affect patients' daily lives and quality of life.
|Condition or disease||Intervention/treatment|
|Colorectal Neoplasms||Other: oxaliplatin|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||September 2016|
|Actual Study Completion Date :||September 2016|
- Oxaliplatin-Specific Neurotoxicity Scale [ Time Frame: up to 12 months ]
- Health related quality of life (Fact-G) Questionnaire [ Time Frame: up to 12 months ]
- Sense of Coherence scale (SOC-scale) [ Time Frame: up to 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02412683
|Linkoping, Sweden, 58183|
|Study Director:||Carina Bertero, RN,professor||Department of Health Sciences|